Mayes Patrick A Sold 2207 INCYTE CORP Shares at $123.99
On August 10, 2026, Mayes Patrick A, EVP & Chief Scientific Officer of INCYTE CORP, sold 2207 shares at $123.99 each for a total of $273,645. This transaction was revealed through the mandatory Form 4 filing with the SEC.
On August 10, 2026, Mayes Patrick A, EVP & Chief Scientific Officer of INCYTE CORP, sold 2207 INCYTE CORP shares at $123.99 each for a total of $273,645.
Who is Mayes Patrick A and What is His Real Role at INCYTE CORP
Mayes Patrick A is the EVP & Chief Scientific Officer of INCYTE CORP, meaning he is responsible for the company's scientific direction and development strategies. As a member of senior management, he has access to privileged information about the company's projects and performance, enabling him to make informed decisions regarding investments and share transactions.
As the Chief Scientific Officer, Mayes Patrick A plays a key role in shaping the company's scientific strategy, including identifying opportunities for new drug development and overseeing clinical trials. He also works closely with other members of senior management to align the company's scientific objectives with its commercial goals.
The role of Mayes Patrick A provides him with a unique perspective on the company's performance and prospects, which can influence his decisions regarding share transactions. However, it is important to note that transactions made by insiders are not necessarily indicative of the company's future performance.
Transaction Details: 2207 shares at $123.99 each
The transaction carried out by Mayes Patrick A involved the sale of 2207 INCYTE CORP shares at $123.99 each, totaling $273,645. It is important to distinguish between the per-share price, which is $123.99, and the total value of the transaction, which amounts to $273,645. These two figures are distinct and provide different insights into the transaction.
The date of the transaction was August 10, 2026, meaning the Form 4 filing with the SEC was made within two business days following the transaction, as required by SEC rules. This filing provides investors with visibility into the transactions carried out by insiders, which can help them make informed decisions about their own investments.
Why Insiders Sell Their Shares - Possible Reasons
There are several reasons why insiders like Mayes Patrick A might choose to sell their shares. One of the most common reasons is diversifying their investment portfolio. Insiders often have a significant portion of their wealth invested in their own company's shares, which can expose them to high risk if the company's performance declines. By selling a portion of their shares, they can reduce their exposure to this risk and diversify their investments.
Another possible reason is tax planning. Insiders may sell their shares to realize capital gains, which can allow them to pay taxes on these gains in a more efficient manner. They may also use the proceeds from the sale of their shares to fund other investments or cover personal expenses.
Additionally, insiders may sell their shares due to concerns about the company's future performance. If they have reservations about the company's prospects, they may decide to sell their shares to minimize potential losses. However, it is important to note that transactions made by insiders are not necessarily indicative of the company's future performance.
